The Daily Mail reported that,
Cambridge-based AstraZeneca… acknowledged in a legal document submitted to the High Court in February that its vaccine 'can, in very rare cases, cause TTS'.

TTS is short for thrombosis with thrombocytopenia syndrome – a medical condition where a person suffers blood clots along with a low platelet count. Platelets typically help the blood to clot.

The admission by AstraZeneca is the first of its kind.

The question now is – if you got the vaccine, what can you do about it?
Dr. Peter McCullough has been one of the leading experts on treating long COVID and the health impacts from COVID-19 vaccines. Since very early on in this process, Nattokinase has shown great potential in treating some of the most serious side effects of both.
According to Dr. McCullough, the threat of micro blood clotting is serious for those impacted by long COVID and the vaccine:
Post-acute sequelae after SARS-CoV-2 infection (long COVID) and after COVID-19 vaccination are characterized by micro blood clotting . The work of Scheim et al suggests the majority of syndromes in both cases are due to Spike protein mediated hemagglutination and then the development of small clots that serve the major organs in the body. Xi et al demonstrated increased risk for microclots visualized in retinal arteries and veins in the COVID-19 vaccinated.